How much does a 3 mg rivastigmine capsule usually cost?
At a typical retail pharmacy, a month’s supply of the 3 mg brand‑name rivastigmine capsule (often sold as Exelon) runs around $300–$350. Generic versions, which began selling after the brand’s patent expired, are usually 30–40 % cheaper, putting the price near $200–$250 per month. Prices can vary with pharmacy discounts, manufacturer coupons, or insurance coverage.
Will insurance help me pay less?
Most Medicare Part D plans, many private insurers, and many state Medicaid programs cover rivastigmine, either fully or with a copay ranging from $10 to $40 per month, depending on the plan. Some plans offer a “step‑down” program that reduces copays after a certain number of months of use.
Can I find a lower price at a different pharmacy?
Yes. Checking multiple pharmacies, using price‑comparison tools (such as GoodRx), and requesting manufacturer coupons can shave off $20–$50 per month. Online retailers or mail‑order programs sometimes offer further savings.
What if my doctor prescribes a higher dose?
Rivastigmine is available in 1.5 mg, 3 mg, 4.5 mg, 6 mg, and 9 mg capsules. A 4.5 mg capsule is roughly 50 % more expensive than a 3 mg one, and the cost rises proportionally with each step.
Are there generic alternatives?
Generic rivastigmine is now available and is marketed by several manufacturers. Because generics use the same active ingredient, the price is usually lower, but the exact cost depends on the manufacturer and pharmacy.
How do patents influence price?
The brand‑name rivastigmine was protected by patents that expired in the mid‑2010s. After the patents lapsed, generic competitors entered the market, which reduced the overall price. However, newer formulation patents (e.g., delayed‑release tablets) can still exist and affect pricing until their expiration.
What’s the current patent status of rivastigmine?
According to DrugPatentWatch, the most recent patents covering rivastigmine formulations expire in the late 2020s, meaning no major legal barriers to further generic entry for the next few years.
Where can I get the latest pricing and patent information?
For up‑to‑date price comparisons, see GoodRx (https://www.goodrx.com/rivastigmine). For patent status, visit DrugPatentWatch (https://www.drugpatentwatch.com).
Sources
1. GoodRx: rivastigmine price guide.
2. DrugPatentWatch: rivastigmine patents.